| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15,442 |
14,707 |
$1.98M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,453 |
12,948 |
$1.36M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
4,973 |
4,784 |
$968K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,628 |
11,296 |
$849K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,938 |
3,825 |
$333K |
| 80053 |
Comprehensive metabolic panel |
29,245 |
27,113 |
$304K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,383 |
1,348 |
$236K |
| G0378 |
Hospital observation service, per hour |
322 |
234 |
$218K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,098 |
6,845 |
$191K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,084 |
2,021 |
$165K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,623 |
28,340 |
$161K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,083 |
1,866 |
$129K |
| 87631 |
|
857 |
834 |
$121K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,392 |
5,241 |
$113K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,509 |
1,361 |
$91K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,662 |
9,163 |
$85K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,189 |
5,950 |
$81K |
| 0100U |
|
204 |
191 |
$78K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,403 |
4,226 |
$77K |
| 80061 |
Lipid panel |
5,739 |
5,651 |
$73K |
| 84484 |
|
8,111 |
6,804 |
$72K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,071 |
1,470 |
$62K |
| 87481 |
|
853 |
829 |
$62K |
| 70450 |
Computed tomography, head or brain; without contrast material |
986 |
953 |
$60K |
| 84702 |
|
3,574 |
3,338 |
$57K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
286 |
276 |
$57K |
| 71046 |
Radiologic examination, chest; 2 views |
3,409 |
3,313 |
$55K |
| 71045 |
Radiologic examination, chest; single view |
5,752 |
5,544 |
$50K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,926 |
1,888 |
$48K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,757 |
5,483 |
$42K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
440 |
430 |
$42K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,218 |
1,200 |
$40K |
| 0002A |
|
1,095 |
1,095 |
$40K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,653 |
1,621 |
$40K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,402 |
4,735 |
$39K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
136 |
134 |
$37K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
929 |
907 |
$37K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
443 |
441 |
$35K |
| 0001A |
|
1,122 |
1,120 |
$35K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
178 |
177 |
$33K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
145 |
144 |
$33K |
| 62323 |
|
61 |
61 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
704 |
694 |
$31K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
334 |
334 |
$30K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
872 |
849 |
$29K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,802 |
4,709 |
$29K |
| 83690 |
|
5,824 |
5,553 |
$27K |
| 87150 |
|
305 |
299 |
$26K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
290 |
203 |
$26K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
199 |
182 |
$26K |
| 300 |
Patient transfer system <300 |
182 |
43 |
$24K |
| 82607 |
|
2,050 |
2,019 |
$24K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
84 |
82 |
$24K |
| 83605 |
|
3,351 |
3,113 |
$23K |
| 85027 |
|
4,201 |
3,555 |
$22K |
| 80050 |
General health panel |
493 |
484 |
$21K |
| 76830 |
Ultrasound, transvaginal |
374 |
363 |
$21K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
287 |
282 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
688 |
682 |
$19K |
| 71250 |
|
276 |
274 |
$18K |
| 83880 |
|
682 |
655 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
9,834 |
7,937 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,517 |
1,404 |
$17K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
400 |
397 |
$16K |
| 76642 |
|
331 |
286 |
$16K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
827 |
707 |
$16K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
512 |
509 |
$16K |
| 81001 |
|
5,630 |
5,392 |
$15K |
| 82728 |
|
1,404 |
1,365 |
$15K |
| 83735 |
|
2,591 |
2,300 |
$14K |
| 86803 |
|
765 |
755 |
$14K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
186 |
180 |
$14K |
| 87430 |
|
2,038 |
1,988 |
$13K |
| 76770 |
|
225 |
223 |
$12K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
163 |
152 |
$12K |
| 82805 |
|
406 |
381 |
$11K |
| X0621 |
|
53 |
38 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,067 |
1,025 |
$11K |
| 83540 |
|
1,298 |
1,268 |
$10K |
| T1015 |
Clinic visit/encounter, all-inclusive |
301 |
192 |
$9K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
287 |
287 |
$9K |
| 0004A |
|
210 |
209 |
$9K |
| 85379 |
|
992 |
925 |
$9K |
| 84439 |
|
1,145 |
1,098 |
$9K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
331 |
313 |
$8K |
| 88342 |
|
190 |
177 |
$8K |
| 87040 |
|
516 |
441 |
$8K |
| 87522 |
Neg quan hep c or qual rna |
199 |
198 |
$8K |
| 93971 |
|
113 |
111 |
$7K |
| 82570 |
|
1,058 |
1,002 |
$7K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
946 |
918 |
$7K |
| 73610 |
|
359 |
327 |
$7K |
| 74183 |
|
13 |
13 |
$7K |
| 81003 |
|
2,374 |
2,265 |
$7K |
| 73564 |
|
278 |
250 |
$6K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
73 |
70 |
$6K |
| 85610 |
|
2,318 |
1,849 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,746 |
3,525 |
$6K |
| 73630 |
|
439 |
395 |
$6K |
| 82043 |
|
802 |
781 |
$6K |
| 87186 |
|
765 |
709 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
27 |
27 |
$5K |
| 82248 |
|
926 |
866 |
$5K |
| 83550 |
|
1,238 |
1,211 |
$5K |
| 86618 |
|
220 |
216 |
$5K |
| 81025 |
|
1,314 |
1,262 |
$5K |
| 74018 |
|
339 |
319 |
$5K |
| 80076 |
|
668 |
606 |
$5K |
| 82746 |
|
458 |
448 |
$5K |
| J1756 |
Injection, iron sucrose, 1 mg |
584 |
317 |
$4K |
| 83655 |
|
394 |
389 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
120 |
85 |
$4K |
| 72100 |
|
175 |
170 |
$4K |
| 84145 |
|
248 |
241 |
$4K |
| 84153 |
|
171 |
171 |
$4K |
| 86850 |
|
546 |
510 |
$4K |
| 73030 |
|
236 |
227 |
$4K |
| 84146 |
|
152 |
148 |
$4K |
| 94060 |
|
410 |
406 |
$4K |
| 86780 |
|
253 |
247 |
$4K |
| 0012A |
|
129 |
129 |
$4K |
| 83615 |
|
702 |
545 |
$4K |
| 87077 |
|
530 |
479 |
$3K |
| 0064A |
|
80 |
80 |
$3K |
| 72141 |
|
13 |
13 |
$3K |
| 76536 |
|
56 |
56 |
$3K |
| 77065 |
Tomosynthesis, mammo |
53 |
53 |
$3K |
| 86140 |
|
1,138 |
1,055 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
230 |
220 |
$3K |
| 86900 |
|
686 |
595 |
$3K |
| 83970 |
|
81 |
78 |
$3K |
| 86901 |
|
683 |
592 |
$3K |
| 87340 |
|
215 |
213 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
181 |
181 |
$3K |
| 73130 |
|
221 |
207 |
$3K |
| 96376 |
|
112 |
97 |
$3K |
| 84100 |
|
622 |
524 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,707 |
5,525 |
$3K |
| 0072A |
|
63 |
63 |
$3K |
| 93226 |
|
73 |
71 |
$3K |
| 86003 |
|
26 |
26 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
80 |
79 |
$2K |
| 87088 |
|
310 |
297 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
191 |
159 |
$2K |
| 82962 |
|
1,528 |
1,033 |
$2K |
| 80081 |
|
25 |
25 |
$2K |
| 73502 |
|
107 |
103 |
$2K |
| 88341 |
|
29 |
25 |
$2K |
| 72110 |
|
79 |
79 |
$2K |
| 73110 |
|
153 |
144 |
$2K |
| 0071A |
|
47 |
47 |
$2K |
| 90715 |
|
418 |
414 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
173 |
170 |
$2K |
| 94729 |
|
65 |
65 |
$2K |
| 0011A |
|
108 |
107 |
$2K |
| 82950 |
|
250 |
248 |
$2K |
| 86038 |
|
115 |
114 |
$2K |
| 93017 |
|
45 |
45 |
$2K |
| 70486 |
|
24 |
24 |
$2K |
| 82375 |
|
408 |
383 |
$2K |
| 84481 |
|
74 |
70 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
55 |
52 |
$2K |
| 12001 |
|
65 |
64 |
$2K |
| 86592 |
|
388 |
384 |
$2K |
| 82550 |
|
263 |
237 |
$2K |
| 82565 |
|
267 |
262 |
$2K |
| 86762 |
|
78 |
76 |
$2K |
| 83525 |
|
139 |
135 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,468 |
1,252 |
$1K |
| 85652 |
|
501 |
485 |
$1K |
| 94726 |
|
52 |
52 |
$1K |
| 82150 |
|
320 |
316 |
$1K |
| 85046 |
|
251 |
241 |
$1K |
| 77066 |
Tomosynthesis, mammo |
13 |
13 |
$1K |
| 82977 |
|
201 |
141 |
$1K |
| 87070 |
|
193 |
185 |
$1K |
| 86431 |
|
157 |
154 |
$1K |
| 82784 |
|
54 |
52 |
$1K |
| 84156 |
|
272 |
230 |
$1K |
| 80164 |
|
70 |
66 |
$1K |
| 73590 |
|
55 |
50 |
$1K |
| 0003A |
|
23 |
23 |
$950.20 |
| 93320 |
|
24 |
24 |
$934.46 |
| 85730 |
|
157 |
154 |
$901.47 |
| 84550 |
|
163 |
153 |
$899.47 |
| 83050 |
|
406 |
381 |
$861.60 |
| 93225 |
|
51 |
50 |
$844.44 |
| 86317 |
|
41 |
41 |
$828.34 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
38 |
38 |
$779.42 |
| 73080 |
|
63 |
62 |
$778.77 |
| 11721 |
|
59 |
57 |
$756.00 |
| 94664 |
|
96 |
93 |
$746.64 |
| 85018 |
|
241 |
239 |
$739.22 |
| 80179 |
|
13 |
12 |
$733.26 |
| 84403 |
|
25 |
25 |
$731.16 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
646 |
533 |
$668.84 |
| 82947 |
|
169 |
168 |
$664.30 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
31 |
25 |
$645.45 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
947 |
885 |
$645.37 |
| 80074 |
|
13 |
13 |
$627.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,409 |
4,921 |
$605.31 |
| 74022 |
|
32 |
30 |
$602.21 |
| 20552 |
|
28 |
27 |
$599.96 |
| 85007 |
|
146 |
135 |
$583.39 |
| 87511 |
|
26 |
26 |
$578.60 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,586 |
2,542 |
$549.10 |
| 93296 |
|
74 |
74 |
$529.48 |
| 94618 |
|
41 |
40 |
$523.09 |
| 87641 |
|
14 |
12 |
$513.91 |
| 84460 |
|
78 |
75 |
$493.33 |
| 83001 |
|
27 |
27 |
$489.69 |
| 82785 |
|
26 |
26 |
$479.93 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,468 |
6,456 |
$447.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
73 |
71 |
$433.52 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$415.19 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,053 |
913 |
$391.83 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,012 |
2,849 |
$357.28 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,262 |
2,772 |
$352.50 |
| J2704 |
Injection, propofol, 10 mg |
1,433 |
1,140 |
$347.85 |
| 86705 |
|
25 |
24 |
$341.78 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
209 |
202 |
$309.20 |
| 90686 |
|
49 |
47 |
$291.44 |
| 87205 |
|
70 |
60 |
$271.79 |
| G0008 |
Administration of influenza virus vaccine |
64 |
64 |
$271.20 |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,440 |
2,322 |
$260.22 |
| 82103 |
|
14 |
14 |
$259.42 |
| 71101 |
|
12 |
12 |
$251.02 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
339 |
334 |
$237.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,670 |
1,503 |
$208.74 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
29 |
27 |
$205.00 |
| 86200 |
|
13 |
13 |
$204.72 |
| 86800 |
|
12 |
12 |
$201.12 |
| 86039 |
|
12 |
12 |
$179.85 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,021 |
878 |
$160.68 |
| 82077 |
|
19 |
18 |
$152.90 |
| 87046 |
|
68 |
67 |
$150.75 |
| 73140 |
|
13 |
13 |
$150.63 |
| 88304 |
|
27 |
26 |
$147.19 |
| 83721 |
|
16 |
16 |
$136.97 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
281 |
187 |
$128.99 |
| 80069 |
|
16 |
16 |
$125.45 |
| 80178 |
|
14 |
13 |
$103.29 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,103 |
1,043 |
$98.40 |
| 72170 |
|
13 |
13 |
$85.43 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
12 |
12 |
$49.90 |
| J2060 |
Injection, lorazepam, 2 mg |
103 |
94 |
$44.79 |
| 84520 |
|
12 |
12 |
$41.98 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,123 |
1,999 |
$34.27 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
132 |
103 |
$24.14 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
157 |
156 |
$19.03 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
68 |
53 |
$10.16 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
549 |
509 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
392 |
368 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
49 |
48 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
266 |
266 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
46 |
44 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
45 |
34 |
$0.00 |
| J1750 |
Injection, iron dextran, 50 mg |
14 |
13 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
26 |
25 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
246 |
161 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
60 |
59 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
20 |
13 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
30 |
30 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
13 |
12 |
$0.00 |
| 90656 |
|
56 |
56 |
$0.00 |
| J1597 |
Injection, glycopyrrolate (glyrx-pf), 0.1 mg |
56 |
56 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
76 |
68 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
13 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
12 |
12 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
41 |
13 |
$0.00 |